STC2 and invasive breast carcinoma: The STC2 is positively correlated with MSI including LIHC, LUSC, ovarian serous cystadenocarcinoma (OV), SARC, TGCT, THYM and negatively correlated with breast invasive carcinoma (BRCA), and COAD (Figure 2A).